Renovia’s leva® Pelvic Health System is First Femtech Offering Included in Product Library of Digital Therapeutics Alliance September 20, 2021
Verastem Oncology Announces Updated Investigator-Sponsored Phase 1/2 FRAME Study Data of VS-6766 with Defactinib in Low-Grade Serous Ovarian Cancer Showing Encouraging Response Rates and Progression-Free Survival Presented at ESMO 2021 September 20, 2021
Pyxis Oncology Names New CMO to Lead Development of Next-Gen Antibody-Drug Conjugates September 20, 2021
